ANI Pharmaceuticals
NasdaqGM:ANIP
$ 72,82
$-1,32 (-1,78%)
72,82 $
$-1,32 (-1,78%)
End-of-day quote: 03/27/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

$7,89
Earnings Per Share
$42,31
Revenue Per Share
61,36%
Gross Margin %
$1,55 B
Market Cap
$0,60 B
Long-Term Debt
Earnings Per Share
$7,89
Revenue Per Share
$42,31
Gross Margin %
61,36%
Market Cap
$1,55 B
Long-Term Debt
$0,60 B

Financials

Year Year 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
EPS Earnings Per Share $7,89 $5,20 $4,71 $1,36 $3,20 $3,50 $5,06 $5,07 $3,91 $2,96 $2,72 $1,48 $-0,96
Earnings Earnings $164,74M $105,61M $92,88M $22,24M $52,96M $42,00M $60,21M $60,08M $45,55M $34,31M $31,14M $16,86M $-9,25M
RPS Revenue Per Share $0,00 $42,31 $30,25 $24,69 $19,35 $13,06 $17,37 $17,36 $17,01 $15,18 $11,10 $6,67 $4,91 $3,12
Revenue Revenue $0,00M $883,37M $614,38M $486,82M $316,39M $216,14M $208,48M $206,55M $201,58M $176,84M $128,62M $76,32M $55,97M $30,08M
OCF Operating Cash Flow $0,00M $169,72M $64,02M $118,96M $-31,20M $3,32M $15,27M $45,63M $67,07M $0,00M $27,47M $17,26M $22,03M $-5,48M
FCF Free Cash Flow $0,00M $153,99M $47,78M $82,79M $-40,08M $0,77M $0,00M $0,00M $45,24M $-74,81M $0,00M $0,00M $0,00M $0,00M
OM Operating Margin 0,00% 9,20% 2,38% 10,17% -8,13% -13,03% -7,47% 7,95% 17,54% 16,53% 26,41% 42,84% 38,07% 21,27%
GM % Gross Margin % 0,00% 61,36% 59,27% 62,71% 56,13% 53,45% 58,19% 69,42% 63,77% 55,31% 66,66% 83,37% 79,50% 66,84%
FCFS Free Cash Flow Per Share $0,00 $7,47 $2,35 $5,49 $-3,03 $-1,63 $-4,43 $1,53 $4,81 $-5,94 $-10,62 $-1,36 $-1,25 $-1,12
LT Debt Long-Term Debt N/A $599,77M $614,92M $284,82M $285,67M $286,52M $186,55M $182,02M $67,79M $198,15M $120,64M $113,43M $106,54M N/A
Sha. Stocks 22,41M 20,88M 20,31M 19,72M 16,35M 16,55M 12M 11,9M 11,85M 11,65M 11,59M 11,45M 11,39M 9,64M
×